These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey. Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874 [TBL] [Abstract][Full Text] [Related]
3. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers. Morrison AE; Senior PA; Bubela T; Farnsworth K; Witteman HO; Lam A Can J Diabetes; 2022 Dec; 46(8):863-870. PubMed ID: 35945126 [TBL] [Abstract][Full Text] [Related]
4. Learning challenges of healthcare professionals supporting open-source automated insulin delivery. Crocket H; Lewis DM; Burnside M; Faherty A; Wheeler B; Frewen C; Lever C; Jefferies C; Williman J; Sanders O; Wilson R; Paul R; Price S; Jones S; de Bock M Diabet Med; 2022 May; 39(5):e14750. PubMed ID: 34826158 [TBL] [Abstract][Full Text] [Related]
5. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals. Jennings P; Hussain S J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570 [TBL] [Abstract][Full Text] [Related]
6. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals. Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329 [TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
8. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Sherr JL; Heinemann L; Fleming GA; Bergenstal RM; Bruttomesso D; Hanaire H; Holl RW; Petrie JR; Peters AL; Evans M Diabetes Care; 2022 Dec; 45(12):3058-3074. PubMed ID: 36202061 [TBL] [Abstract][Full Text] [Related]
9. Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine. Burnside M; Crocket H; Mayo M; Pickering J; Tappe A; de Bock M J Diabetes Sci Technol; 2020 Sep; 14(5):878-882. PubMed ID: 31876179 [TBL] [Abstract][Full Text] [Related]
11. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review. Knoll C; Peacock S; Wäldchen M; Cooper D; Aulakh SK; Raile K; Hussain S; Braune K Diabet Med; 2022 May; 39(5):e14741. PubMed ID: 34773301 [TBL] [Abstract][Full Text] [Related]
12. Do-it-yourself closed-loop systems for people living with type 1 diabetes. Dowling L; Wilmot EG; Choudhary P Diabet Med; 2020 Dec; 37(12):1977-1980. PubMed ID: 32420640 [TBL] [Abstract][Full Text] [Related]
13. User and Healthcare Professional Perspectives on Do-It-Yourself Artificial Pancreas Systems: A Need for Guidelines. Shepard JA; Breton M; Nimri R; Roberts JTF; Street T; Klonoff D; Barnard-Kelly K J Diabetes Sci Technol; 2022 Jan; 16(1):224-227. PubMed ID: 33000636 [TBL] [Abstract][Full Text] [Related]
14. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563 [TBL] [Abstract][Full Text] [Related]
15. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes. Lewis DM; Hussain S Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655 [TBL] [Abstract][Full Text] [Related]
16. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G. Jeyaventhan R; Gallen G; Choudhary P; Hussain S Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488 [TBL] [Abstract][Full Text] [Related]
17. Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/APEG/ADIPS Working Group. Pease AJ; Andrikopoulos S; Abraham MB; Craig ME; Fenton B; Overland J; Price S; Simmons D; Ross GP Med J Aust; 2021 Nov; 215(10):473-478. PubMed ID: 34148253 [TBL] [Abstract][Full Text] [Related]